| Year | 2008-2012 |
| Company | William Ransom & Son plc |
| Sector | Pharmaceuticals |
| Activity | Manufacture and distribution of branded healthcare products |
| Ownership | AIM listed/delisted |
| Icknield role Key achivements |
Initially cash management followed by interim FD and later CRO Share suspension lifted |
| Additional funding need avoided through active cash management Debt reduced through disposal proceeds and working capital reduction Refinanced Delisted to complete turnaround in non-public arena followed by sale of divisions and return of net proceeds to shareholders |
|
| Contact for further info | ran@icknield.com |
William Ransom & Son plc
